MannKind – Developing pulmonary therapies and devices that help give people more control of their health

Changing lives for the better

Our founder, Alfred E. Mann was a visionary in aerospace, medical technology, and biopharmaceuticals. But his true passion was helping others. It’s a simple notion with a profound impact. Since 1991, MannKind has been dedicated to developing therapies and devices that give people more control of their health–and the freedom to live life to its fullest.

Thinking beyond what’s possible

Our team of dedicated scientists and medical professionals are committed to developing inhaled therapeutic products to meet the needs of patients. How do we do it? By seeking open feedback and new ideas, encouraging expansive thinking, and challenging conventional wisdom at every turn.

Enhancing Clinical Research

A comprehensive approach to clinical trials helps ensure our research produces accurate and reliable results. By studying a wide range of patient populations, we develop more effective treatments and advance medical solutions that benefit broader healthcare needs.

Transformative impact in pulmonary medicine

Leveraging our expertise in formulation and device engineering, we’ve helped alleviate the burden of diseases like diabetes and pulmonary hypertension (PAH and PH-ILD). And we’ve got more solutions on the way to meet the needs of people with nontuberculous mycobacterial (NTM) lung disease and pulmonary fibrotic diseases. Our ongoing research holds promise for improving pulmonary health outcomes and enhancing the quality of life for patients worldwide.

Explore our pipeline